Marina Planas is a multidisciplinary innovator at the forefront of biotech, digital platforms, and health. As CEO of Altum Sequencing, she leads the development of precision oncology tools, harnessing liquid biopsy and advanced genomics to make cutting-edge science accessible and impactful in clinical practice.

With a diverse background spanning engineering, entrepreneurship, and over 17 years in the automotive sector, Marina brings a unique perspective to the Medtech space. She is also co-founder of TheNTWK, Europe’s leading community for platform business innovators, and a partner of the MIT platform strategy program.

Under her leadership, Altum Sequencing is revolutionizing cancer monitoring with non-invasive, real-time tools powered by NGS and personalized medicine. Her experience scaling innovation in healthtech across Europe, China, and the US offers valuable lessons for building global biotech startups.